TSE:SLF

Sun Life Financial Inc (SLF.TO)

102.80
+1.38 (1.36%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
720 watching
0
Investor Insights
star iconJun 5, 2026, 12:00 am

This summary was created by AI, based on 12 opinions in the last 12 months.

Sun Life Financial Inc (SLF) is presently facing a challenging landscape, with mixed reviews from experts highlighting both the strengths and weaknesses of the company. Some analysts praise its strong management and growth potential in Asia, particularly in asset management, whereas others express concerns regarding its performance in the U.S. dental market and overall growth, particularly as compared to peers like Manulife Financial Corporation (MFC). Despite trading at a lower P/E ratio compared to Canadian banks, some experts argue that the stock's current valuation isn't compelling given the subdued growth prospects. However, SLF is recognized for its consistent dividend growth and stable earnings, and the recent share repurchases are seen as a positive move. Analysts are divided, with some asserting a long-term bullish outlook while others remain cautious pending macroeconomic or company-specific catalysts.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
MFC
BUY
Insurance should continue to improve.
BUY
14 X this years earnings.
HOLD
Likes both Manulife and Sun life. Likes the Clarica acquisition. It may be weak for a while as fund managers may have to reduce some of their holdings for better portfolio balance.
BUY
Good long term hold. Reasonable price.
BUY
A great company for a long term hold.
BUY
BUY
Acquisition of Clarica is a good move. Insurance sector is solid.
PAST TOP PICK
(Was a top pick on Oct 2 up 12%) Good valluations.
BUY
Good management. A long term hold.
PAST TOP PICK
(Was a top pick on Mar 14 up 3.5%) Still likes.
TOP PICK
Looking for earnings to grow in the 15% range. Good acquisitions.
BUY
Made a good acquisition.
TOP PICK
Expects it to be a world class company.
TOP PICK
Likes the acquisition of Clarica. Should do well in capital market growth.
BUY ON WEAKNESS
Would buy in the $31/32 range. Good long term.
Showing 931 to 945 of 1,049 entries